Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of BioAge Labs Inc (NASDAQ: BIOA) closed at $3.40 in the last session, down -2.58% from day before closing price of $3.49. In other words, the price has decreased by -$2.58 from its previous closing price. On the day, 0.52 million shares were traded. BIOA stock price reached its highest trading level at $3.49 during the session, while it also had its lowest trading level at $3.34.
Ratios:
We take a closer look at BIOA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.86 and its Current Ratio is at 12.86. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 10, 2024, Morgan Stanley Downgraded its rating to Underweight which previously was Overweight and also lowered its target price recommendation from $40 to $5.
Jefferies Downgraded its Buy to Hold on December 09, 2024, whereas the target price for the stock was revised from $42 to $7.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when Barton Shane bought 2,632 shares for $18.00 per share. The transaction valued at 47,376 led to the insider holds 2,632 shares of the business.
Pande Vijay Satyanand bought 126,793 shares of BIOA for $2,501,626 on Oct 01 ’24. The Director now owns 1,026,793 shares after completing the transaction at $19.73 per share. On Oct 02 ’24, another insider, Pande Vijay Satyanand, who serves as the Director of the company, bought 67,096 shares for $19.73 each. As a result, the insider paid 1,323,804 and bolstered with 1,093,889 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOA now has a Market Capitalization of 121890000 and an Enterprise Value of -223754880.
Stock Price History:
Over the past 52 weeks, BIOA has reached a high of $26.62, while it has fallen to a 52-week low of $3.47. The 50-Day Moving Average of the stock is -23.04%, while the 200-Day Moving Average is calculated to be -69.55%.
Shares Statistics:
According to the various share statistics, BIOA traded on average about 238.82K shares per day over the past 3-months and 294190 shares per day over the past 10 days. A total of 35.85M shares are outstanding, with a floating share count of 21.04M. Insiders hold about 41.30% of the company’s shares, while institutions hold 30.56% stake in the company. Shares short for BIOA as of 1741910400 were 1752940 with a Short Ratio of 7.34, compared to 1739491200 on 1993898.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
